all report title image
  • Published On : Dec 2022
  • Code : CMI5381
  • Industry : Biotechnology
  • Pages : 168
  • Formats :

The global stem cell manufacturing market was valued at US$ 8,584.2 Mn in 2021 and is forecast to reach a value of US$ 20,428.1 Mn by 2028 at a CAGR of 13.3% between 2021 and 2028. The stem cell manufacturing market is experiencing strong growth due to the increase in prevalence of chronic/neurological diseases and growing awareness among people about therapeutic potential of stem cell. Moreover, increase in focus on the development of stem cell therapies is expected to boost the growth of the market. However, factors such as high cost of stem cell manufacturing and socio-ethical concerns regarding use of human embryonic stem cell are expected to hamper growth of the global stem cell manufacturing market.

Global Stem Cell Manufacturing Market: Regional Insights

Based on geography, the global stem cell manufacturing market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Among regions, North America is expected to gain highest share in the market over the forecast period owing to the growing awareness among people about therapeutic potential of stem cells and robust research infrastructure in the region. For instance, stem cells can be used to replace damaged neurons caused by Alzheimer's & Parkinson’s disease, spinal cord injuries, and other neurological problems. Alzheimer's Association, more than 6 million Americans of all ages have Alzheimer's. Around 6.5 million Americans age 65 and older are living with Alzheimer's in 2022. Over 73% are age 75 or older, and about 1 in 9 age 65 and older (10.7%) has Alzheimer's.

Asia Pacific is also expected to witness robust growth in the global stem cell manufacturing market owing to the increase in prevalence of chronic and neurological disorders and government funding for stem cell research in the region. For instance, in February 2022, the government of India helped set up state-of-the-art stem cell research facilities in 40 premier health research and educational institutions. The government has also spent around US$ 80 million in the recent years under certain research projects through Indian Council of Medical Research (ICMR). This in turn is expected to aid in the growth of the stem cell manufacturing market.

Figure 1. Global Stem Cell Manufacturing Market Share (%), by Region, 2022

Stem Cell Manufacturing  | Coherent Market Insights

Global Stem Cell Manufacturing Market Drivers:

Increase in prevalence of chronic and neurological disorders is expected to augment growth of the global stem cell manufacturing market over the forecast period. Stem cells can be used to replace damaged neurons caused by spinal cord injuries, Parkinson’s and Alzheimer's disease, and other neurological problems. Stem cell therapy may be a viable treatment option for Parkinson's disease. According to the World Health Organization (WHO), globally, the prevalence of Parkinson disease (PD) has doubled in the past 25 years with global estimates in 2019 showing more than 8.5 million individuals living with Parkinson disease.

Growing awareness among people about therapeutic potential of stem cell is expected to boost the growth of the global stem cell manufacturing market over the forecast period. For instance, today, doctors routinely use stem cells to treat patients with cancer and disorders of the blood and immune system. According to WHO, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths. The most common cancers are breast, lung, colon and rectum and prostate cancers. Thus, players in the market are focusing on introducing new stem cell therapies for the cancer treatment.

Global Stem Cell Manufacturing Market Opportunities:

Increase in focus on the development of stem cell therapies is expected to offer significant growth opportunities for players in the stem cell manufacturing market. For instance, players in the market are focusing on introducing new stem cell therapies due to increase in burden of both chronic and neurological disorders worldwide. In September 2022, Alkem Laboratories, in collaboration with Stempeutics, launched stem cell therapy product, StemOne, to treat Knee Osteoarthritis (OA) after receiving a regulatory approval from the Drugs Controller General of India (DCGI).

Growing public awareness of the benefits of stem cell preservation is expected to offer significant growth opportunities for players in the stem cell manufacturing therapeutics market. For instance, stem cell preservation has been the latest craze among people, as these cells can be used to treat various life-threatening diseases, such as chronic and neurological disorders. Therefore, with the rise in prevalence of chronic and neurological diseases, the trend of stem cell preservation is also increasing with a rapid pace worldwide. This in turn provides opportunities for market players as they focus on R&D activities to introduce new stem cell therapies.

CMI table icon

Stem Cell Manufacturing Market Report Coverage

Report Coverage Details
Base Year: 2021 Market Size in 2021: US$ 9,672.0 Mn
Historical Data for: 2017 to 2020 Forecast Period: 2022 to 2028
Forecast Period 2022 to 2028 CAGR: 13.3% 2028 Value Projection: US$ 20,428.1 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Type: Product and Services
  • By Application: Stem Cell Therapy, Drug Discovery and Development, and Stem Cell Banking
  • By End-User: Pharmaceutical and Biotechnology Companies & CRO, Cell Banks and Tissue Banks, and Others
Companies covered:

TAKARA BIO Inc., PHARMICELL Co., Ltd., MEDIPOST Co., Holostem Terapie Avanzate S.r.l, Bio-Rad Laboratories, Anterogen Co., Ltd., Osiris Therapeutics, Inc (Smith & Nephew PLC), Minaris Regenerative Medicine (Hitachi Chemical Co., Ltd.), Nikon CeLL Innovation Co. Ltd. (Nikon Corporation), Medinet Co. Ltd., Cell and Gene Therapy Catapult, Bio Elpida, Miltenyi Biotec, Pluristem Therapeutics Inc., Thermo Fischer Scientific, Merck Group, Corning Incorporated, Stem Cell Technologies, Lonza Group, Becton, Dickinson and Company, Sartorius, and Cellular Dynamics (Fujifilm Holdings Corporation, among others.

Growth Drivers:
  • Increase in prevalence of chronic and neurological disorders
  • Growing awareness among people about therapeutic potential of stem cell
Restraints & Challenges:
  • High cost associated with stem cell manufacturing
  • Socio-ethical concerns regarding use of human embryonic stem cell

Global Stem Cell Manufacturing Market Trends:

Stem cells hold great promise for new medical treatments, and with the breakthrough in stem cells, there are an increasing number of clinical trials around the world. Stem cells can be used to treat various life-threatening, chronic and neurological disorders, such as cancer, diabetes, Parkinson’s disease, Alzheimer's disease, and others. Thus, with the increase in burden of such diseases, the number of clinical trials is also increasing rapidly. This trend is expected to continue during the forecast period, driving the growth of the market.

Favorable government initiatives and support for research and development (R&D) of regenerative medicine across the globe have increased demand for stem cell manufacturing. Stem cell therapy, or regenerative medicine, promotes the repair response of diseased, injured, or dysfunctional tissue using stem cells or their derivatives. Stem cells offer great promise for new medical treatments. This trend is expected to continue over the forecast period.

Global Stem Cell Manufacturing Market Restraints:

High cost associated with stem cell manufacturing is expected to hamper growth of the global stem cell manufacturing market. For instance, although stem cell therapies are contributing to the well-being of individuals suffering from incurable diseases, the cost of stem cell manufacturing acts as a constraint in the growth of the studied market.

Socio-ethical concerns regarding use of human embryonic stem cell is expected to hinder growth of the global stem cell manufacturing market. For instance, human embryonic stem cell research is ethically and politically controversial because it involves the destruction of human embryos. In the U.S., the question of when human life begins has been highly controversial and closely linked to the debate over abortion.

Figure 2. Global Stem Cell Manufacturing Market Share (%), by Type, 2022

Stem Cell Manufacturing  | Coherent Market Insights

Global Stem Cell Manufacturing Market Segmentation:

The global stem cell manufacturing market report is segmented into Type, Application, End-User, and Geography.

Based on Type, the market is segmented into Product and Services. Of which, Product Segment is expected to dominate the global stem cell manufacturing market during the forecast period and this is attributed to the increase in development of regenerative medicines. Stem cells hold great promise for new medical treatments.

Based on Application, the market is segmented into Stem Cell Therapy, Drug Discovery and Development, and Stem Cell Banking. Out of which, Stem Cell Therapy Segment is expected to dominate the market over the forecast period and this is attributed to the increase in prevalence of chronic and neurological disorders across the globe.

Stem Cell Banking Segment is also expected to witness significant growth in the near future and this is owing to the growing public awareness of the benefits of stem cell preservation.

Based on End-User, the market is segmented into Pharmaceutical and Biotechnology Companies & CRO, Cell Banks and Tissue Banks, and Others. Of which, Pharmaceutical and Biotechnology Companies & CRO Segment is expected to dominate the market over the forecast period and this is attributed to the rise in use of stem cells or adult stem cells for drug development. Major Pharma companies using stem cells for drug development projects

Cell Banks and Tissue Banks Segment is also expected to witness significant growth in the near future and this is due to the increase in stem cell preservation. Preservation of stem cells is critical for both research and clinical application of stem-cell based therapies.   

Global Stem Cell Manufacturing Market: Key Developments

In December 2020, Sartorius AG signed an agreement with Israeli Cell Culture media developer and manufacturer, Biological Industries, to acquire a major stake, increasing the company’s cell culture media product portfolio.

In February 2020, Becton, Dickinson and Company announced its strategic partnership agreement with Babson Diagnostics for small volume blood sample collections in retail pharmacies.

In May 2020, Lonza Group announced its collaboration with Moderna for the manufacture of Moderna’s Vaccine (mRNA-1273) against coronavirus.

Global Stem Cell Manufacturing Market: Key Companies Insights

The global stem cell manufacturing market is highly competitive. This is attributed to the increase in burden of chronic and neurological disorders around the world, as a result, players in the market are focusing on launching novel products in the market.

Some of the key players in the global stem cell manufacturing market are:

TAKARA BIO Inc., PHARMICELL Co., Ltd., MEDIPOST Co., Holostem Terapie Avanzate S.r.l, Bio-Rad Laboratories, Anterogen Co., Ltd., Osiris Therapeutics, Inc (Smith & Nephew PLC), Minaris Regenerative Medicine (Hitachi Chemical Co., Ltd.), Nikon CeLL Innovation Co. Ltd. (Nikon Corporation), Medinet Co. Ltd., Cell and Gene Therapy Catapult, Bio Elpida, Miltenyi Biotec, Pluristem Therapeutics Inc., Thermo Fischer Scientific, Merck Group, Corning Incorporated, Stem Cell Technologies, Lonza Group, Becton, Dickinson and Company, Sartorius, and Cellular Dynamics (Fujifilm Holdings Corporation, among others.

*Definition: Stem cells hold great promise for new medical treatments. Stem cell therapy, also known as regenerative medicine, uses stem cells or their derivatives to promote the repair response of diseased, dysfunctional, or injured tissues. Stem cell manufacturing can be used to develop new stem cell therapies for many untreatable diseases.

Stem cells can be used to develop new stem cell therapies for many untreatable diseases. Stem cell therapy, also known as regenerative medicine, uses stem cells to repair diseased, dysfunctional, or injured tissues. Stem cell therapies can be used to treat neurological, autoimmune, inflammatory, and orthopedic conditions as well as traumatic injuries. Today, doctors routinely use stem cells to treat aforementioned disorders. Stem cells hold great promise for new medical treatments.

Market Dynamics:

Rise in burden of chronic/neurological diseases, increase in focus on the development of stem cell therapies, growing public awareness about therapeutic potential of stem cell, growing awareness regarding the benefits of stem cell preservation, favorable government initiatives and support are major factors expected to aid in the growth of the global stem cell manufacturing market.

For instance, in September 2021, STEMCELL Technologies, in partnership with WiCell, launched human pluripotent stem cell characterization and banking services, making it easier for pluripotent stem cell researchers to achieve critical yet often overlooked steps. Moreover, in September 2021, LifeCell International received an investment of INR 225 crore from OrbiMed Asia Partners IV in return for a minority stake, which will enable the company to make a foray into new categories, such as fertility health and cell-based therapeutics.

Key features of the study:

  • This report provides in-depth analysis of the global stem cell manufacturing market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022–2028), considering 2021 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global stem cell manufacturing market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include TAKARA BIO Inc., PHARMICELL Co., MEDIPOST Co., Holostem Terapie Avanzate S.r.l, Bio-Rad Laboratories, Anterogen Co., Ltd., Osiris Therapeutics, Inc (Smith & Nephew PLC), Minaris Regenerative Medicine (Hitachi Chemical), Nikon CeLL Innovation Co. Ltd. (Nikon Corporation), Medinet Co. Ltd., Cell and Gene Therapy Catapult, Bio Elpida, Miltenyi Biotec, Pluristem Therapeutics Inc., Thermo Fischer Scientific, Merck Group, Corning Incorporated, Stem Cell Technologies, Lonza Group, Becton, Dickinson and Company, Sartorius, and Cellular Dynamics (Fujifilm Holdings Corporation, among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global stem cell manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global stem cell manufacturing market.

Detailed Segmentation:

  • Global Stem Cell Manufacturing Market, By Type:
    • Product
    • Services
  • Global Stem Cell Manufacturing Market, By Application:
    • Stem Cell Therapy
    • Drug Discovery and Development
    • Stem Cell Banking
  • Global Stem Cell Manufacturing Market, By End-User:
    • Pharmaceutical and Biotechnology Companies & CRO
    • Cell Banks and Tissue Banks
    • Others
  • Global Stem Cell Manufacturing Market, By Geography:
    • North America
    • Europe
    • Asia-Pacific
    • Middle East and Africa
    • South America
  • Company Profiles:
    • TAKARA BIO Inc.
    • PHARMICELL Co., Ltd.
    • MEDIPOST Co.
    • Holostem Terapie Avanzate S.r.l.
    • Bio-Rad Laboratories
    • Anterogen Co., Ltd.
    • Osiris Therapeutics, Inc. (Smith & Nephew PLC)
    • Minaris Regenerative Medicine (Hitachi Chemical Co., Ltd.)
    • Nikon CeLL Innovation Co. Ltd. (Nikon Corporation)
    • Medinet Co. Ltd.
    • Cell and Gene Therapy Catapult
    • Bio Elpida
    • Miltenyi Biotec
    • Pluristem Therapeutics Inc.
    • Thermo Fischer Scientific
    • Merck Group
    • Corning Incorporated
    • Stem Cell Technologies
    • Lonza Group
    • Becton, Dickinson and Company
    • Sartorius
    • Cellular Dynamics (Fujifilm Holdings Corporation)

Frequently Asked Questions

The global stem cell manufacturing market size is estimated to be valued at US$ 9,672.0 Million in 2022 and is expected to exhibit a CAGR of 13.3% between 2022 and 2028.
Increase in prevalence of chronic and neurological disorders and growing awareness among people about therapeutic potential of stem cell is fuelling the market.
Product segment is the leading type segment in the market.
High cost associated with stem cell manufacturing and socio-ethical concerns regarding use of human embryonic stem cell are factors restraining growth of the market.
Major players operating in the market are TAKARA BIO Inc., PHARMICELL Co., Ltd., MEDIPOST Co., Holostem Terapie Avanzate S.r.l, Bio-Rad Laboratories, Anterogen Co., Ltd., Osiris Therapeutics, Inc (Smith & Nephew PLC), Minaris Regenerative Medicine (Hitachi Chemical Co., Ltd.), Nikon CeLL Innovation Co. Ltd. (Nikon Corporation), Medinet Co. Ltd., Cell and Gene Therapy Catapult, Bio Elpida, Miltenyi Biotec, Pluristem Therapeutics Inc., Thermo Fischer Scientific, Merck Group, Corning Incorporated, Stem Cell Technologies, Lonza Group, Becton, Dickinson and Company, Sartorius, and Cellular Dynamics (Fujifilm Holdings Corporation, among others.

Related Reports

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo